Hypertension, Dialysis and Clinical Nephrology - Kidney

Time 2021-09-15 12:18:21

Web Name: Hypertension, Dialysis and Clinical Nephrology - Kidney

WebSite: http://www.hdcn.com

ID:193832

Keywords:

and,Dialysis,Hypertension,

Description:

Hemodialysis University 2019Flash or IPAD slide/audioInternational Society for Hemodialysis; Chicago, September 2019PART 5 Glycemic Management in the Patient with CKD Mark Molitch, MDUse of SGLT2 Inhibitors in CKD George Bakris, MD Advances in Chronic Kidney Disease 2020Flash or IPAD slide/audioRenal Research Institute; Los Angeles, CA; January, 2020PARTS 2-4Remote monitoring of peritoneal dialysis patients: a time-tested approachK S Nayak, MDCardio-protective dialysisChristopher McIntyre, MDPD as a treatment option in congestive heart failureMartin Kuhlmann, MDHeat stress and kidney failureMagdalena Madero, MDKidney care for undocumented immigrants in USMitch Rosner, MDDialysis treatment in patients with extreme electrolyte disturbancesMarkus Pirklbauer, MDAKI-D in the outpatient dialysis clinicLorien Dalrymple, MDManagement of the failed kidney transplantAnthony Langone, MDConcepts and controversies around the new OPTN/UNOS organ allocation schemesKenneth Andreoni, MDManagement of anemia in non-dialysis CKD: quo vadisRoberto Pecoits-Filho, MDKidney discards and missed opportunities for transplantationSumit Mohan, MD Reserpine for refractory hypertension Hypertrophic cardiomyopathy new treatments Dapagliflozin and PAD Single-nephron GFR and obesity Sodium intake and density in NHANES Inhaled acetylsalicylic acid Expanded hemodialysis early results Fructose and exercise-induced hypoglycemia Podocyte stress and BP Optimal timing of anti-HTN Rx Cuffless BP monitoring CGM may underestimate hypoglycemia Inpatient CGM during the pandemic Microdissection of renal nerves KDIGO 2020 guidelines for diabetes managementCKD, Dialysis Dialysis care for undocumented immigrants Combined PD and HD in Taiwan Apixaban for a. fib. Vitamin K antagonists and circuit clotting EOS789 pan-phosphate transporter inhibitor Implementing KDIGO Hep C in Asia Drug-coated balloons for AV fistulas Hydroxychloroquine tolerance in HD S-equol, indoxyl sulfate, and TMAO and vascular fxn. Direct oral anticoagulants in the elderly Predictors of dialysis symptoms KDOQI practice guideline for nutrition 2020 Angiotensin-neprilysin and renal outcomes in HF Ferric citrate vs. ferrous sulfate Asymptomatic COVID-19 in HD pts. AKI in critically ill pts. with COVID-19 Nephrology and COVID-19 Oxalate nephropathy (review) Restless legs treatments compared Intradialytic change in BP vs. predialysis BP DEBATE: Animal product consumption Dialysate temp. and creatinine clearance in PD Cardiorenal protection with newer diabetic drugs Kidney failure risk equation Laughter therapy for depressive Sx. Surface-area normalized stdKt/V and outcomes in HD Anti-HTN drugs and depression ris Vitamin K supplementation no effect Oxalate nephropathy due to vitamin C in COVID SARS CoV-2 Ab in dialysis patients Dapagliflozin in CKD Increased PAD risk with statins in Taiwan Decline in residual renal after starting HD Temporal changes in dialysate Na Rx Point of care ultrasound for access cannulationClinical Nephrology Furosemide, salt, or fluid restriction for SIADH Rituximab and remission in ANCA-vasculitis Renal biopsy with 16 vs. 18-gauge needles Dexamethasone and Strongyloides superinfection Desmopressin prior to kidney biopsy Serum bicarb and CV events in HTN Gadolinium-based contrast agents in 2020 SGLT-2 inhibitors and ketoacidosis risk Belimumab for lupus nephritis Daratumumab for refractory lupus Intra-abdominal HTN post transplant Salt ups ADPKD progression risk Supportive care vs. immunosuppression for IGAN Predictive equations for net acid load comparedHypertensionRenal potassium switch and salt-sensitive HTN; Dapagliflozin lowers risk of hyperkalemia.CKD, DialysisAntimicrobial barrier cap for catheters; Neural network model to predict AKI; Patient reported experience measures for home HD; Selective cytopheresis in kids; UF and Na removal with tidal PD; Hosp. and day of week in HD vs. PD; Semaglutide slows CKD progression; Proteomic risk assessment of CKD progression in CRIC; Residual kidney fxn. decline before vs. after starting PD; Screening for COVID-19 in HD; Low-dose steroid use for COVID-19; Vadadustat vs. darbepoietin; Roxadustat in nondialysis CKD and in dialysis patients (x3). Secondary hyperparathyroidism ups risk of weight loss and poor outcomes; Puberty and decline of eGFR in kids with CKD; Caffeine and AKI risk with platinum salt chemoRx; Kidney and cancer outcomes for metastatic urothelial Ca; Nephrotoxicity with high-dose methotrexate; SNF472 slows risk of CAC in HD pts.; Icosapent ethyl effects on CV outcomes in CKD; Apabetalone and CV events in pts. with diabetes and CKD.Clinical Nephrology, TransplantationCorrecting eGFR for race; Pregnancy-triggered aHUS; AKI in pts. with COVID-19; Terlipressin for hepatorenal syndrome type 1; Sparsentan for FSGS; Risk factors for AKI during stem cell Tx for AL amyloidosis; Daratumumab for AL amyloidosis; LNP023 for C3 glomerulopathy; Atacicept for IGAN; Obinutuzumab for proliferative lupus nephritis; Belimumab and lupus nephritis; Reversal of diabetic nephropathy after pancreas transplant vs. podocyte loss; Avacopan for ANCA vasculitis; Persistent proteinuria and hematuria bad in vasculitis; Reloxaliase for severe hyperoxaluria.Screening for CAD pretransplant may not be useful; Recurrence of IGAN after transplant; CKD prevalence in pts. with cancer. (Kidney Week 2020...)Click on RSS for details of each news story. Updated: March 06, 2021 (Mar06)The association of standard Kt/V and surface area-normalized standard Kt/V with clinical outcomes in hemodialysis patients Drs. Pattharanitim P, Chauhan K, El Shamy O ad their colleagues studied a large number of HD patients and found more of a monotonic relationship between dialysis dose and survival when surface-area normalized standard Kt/V was the outcome measure; in the October issue of Hemodial Int (more...) Temporal changes in dialysate [Na+] prescription from 1996 to 2018 and their clinical significance as judged from a meta-regression of clinical trialsDrs. Marshal and Karaboyas describe the impact on outcomes of recent changes made by LDOs to the default dialysate Na prescription; in the Oct issue of Seminars in Dialysis. (more...) Drs. Bi, Mu, Tang, and their colleagues give an overview of the pioneers of dialysis in China, and some relatively recent statistics showing how rapidly dialysis is progressing in that country; in the July issue of Hemodial Int (more...) Incorporating patient-reported outcomes (PROs) into dialysis policy: Current initiatives, challenges, and opportunities Dr. Umeukej and colleagues discuss practical and effective ways of collecting PRO data in dialysis patients and acting upon it; in the Jan/Feb issue of Seminars in Dialysis. (more...) Antibiotic locks for the treatment of catheter-related blood stream infection: Still more hope than data Dr. Labriola reviews the evidence, and which treatments are worth trying now; in the Sep/Oct issue of Seminars in Dialysis. (more...) Addressing myths about exercise in hemodialysis patients Drs. Wilund, Jeong, and Greenwood talk about the pros and cons and practical issues related to setting up exercise programs for dialysis patients; in the July/August issue of Seminars in Dialysis. (more...) The promise of bioimpedance for volume management in American dialysis patients: An unfulfilled opportunityDr. Kotanko discuses various methods volume management, focusing on bioimpedance, which is widely used throughout Europe; in the May/June issue of Seminars in Dialysis. (more...) Evaluating CKD/ESRD patient with hepatitis C infection: How to interpret diagnostic testing and assess liver injuryDrs. Cottone and Bhamidimarri discuss how conventional tests of liver involvement in hepatitis C need to be interpreted in patients on dialysis; This is one of many articles focusion on HCV diagnosis and treatment in a special Mar/Apr issue of Seminars in Dialysis. (more...) PTH assays in dialysis patients: Practical considerations Drs. Soliman, Hassan, Yaseen and their colleagues review the different type of PTH assays as well as their reliability; in the Jan/Feb issue of Seminars in Dialysis. (more...) Ultrafiltration rate in conventional hemodialysis: Where are the limits and what are the consequences? Drs. Slinin, Babu, Ishani and their colleagues discuss the evidence that a high UF rate is bad, and also guide us as to what an appropriate target might be; in the Nov/Dec issue of Seminars in Dialysis. (more...) Online measurement of hemodialysis adequacy using effective ionic dialysance of sodium - a review of its principles, applications, benefits, and risks Drs. Aslam, Saggi, Salifu, and colleagues discuss the basics of the concept of sodium conductivity monitoring of dialyzer clearance, as well as the potential applications and pitfalls; in the October issue of Hemodial Int (more...) Drs. Kosmadakis and their colleagues guide us regarding what vaccinatinons are officially recommended, vs. others that may simply be a good idea to give; in the Sept/Oct issue of Seminars in Dialysis. (more...) Drs. Raina, Krishnappa, and Gupta discuss the difficult topic of measuring and managing pain in the context of the current opioid use epidemic in the United States; in the July issue of Hemodial Int (more...) Beta blockers in patients with end-stage renal disease - Evidence-based recommendations Drs. Weir and Herzog discuss the evidence base regarding when use of beta-blockers may be advantageous in patietns with ESRD, and when one should use alternative medications; in the June issue of Seminars in Dialysis. (more...) The nature, consequences, and management of neurological disorders in chronic kidney diseaseDrs. Jabbari and Vaziri review the numerous way in which neurologic issues can arise in dialysis patients; in the April issue of Hemodial Int (more...) Dr. Paul Scheel reviews the responsibilities of a dialysis unit medical director are; in the Mar/Apr issue of Seminars in Dialysis. (more...) Management of hepatitis C virus infection in patients with advanced kidney disease Dr. Craig Gordon has put together a wonderful supplement dealing with all aspects of hepatitis C virus management in CKD. The articles are open access and free CME and CNE credits are available; in the April issue of Hemodial Int (more...) When and how can nephrologists treat hepatitis C virus infection in dialysis patients? In a most timely article, Davis, Chute, Chung and their colleagues review the various potential indications for the use of the marvelous new hepatitis C drugs in dialysis patients. in the Jan/Feb issue of Seminars in Dialysis. (more...) In this high-risk population for arrhythmias, it is logical to try the use of subcutaneous defibrillators. Tushar Vachharajani and colleagues review the potential indications as well as problems; in the January issue of Hemodial Int (more...) Kidney Disease in Type 2 Diabetes: Disease Progression and Emerging TherapiesPhilip Raskin, MD; Jennifer Marks, MD, Jerry Yee, MD, Mark Molitch, MD. (2011) Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics. Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease. The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or medical professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented on this server. Copyright statement: The reader is responsible for discerning the validity, factuality or implications of information posted here. The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original poster and are in no way representative of or endorsed by the owners or administration of this website. The posts on this website are the opinion of the specific author and are not statements of advice, opinion, or factual information on behalf of the owner or administration of HDCN or Medtext, Inc. This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall hdcn.com or Medtext, Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site.Fair Use Notice:This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes.In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember YOU are responsible for what YOU post on the internet and YOU could be sued by the original copyright holder if you do not honor these rules.If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyrightwe may be contacted concerning copyright matters at:Medtext, Inc.15W560 89th StreetBurr Ridge, IL 60527tel: 630-325-3276email: editor -at sign- hdcn.netIf you require a courier address please send a fax or email and we will provide you with the required information.In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein.If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question. It is our strict policy to disable access to accounts of repeat copyright violation offenders. We will also ban the IP address of repeat copyright violators from future posting on this website with or without a registered account.All 3rd party material posted on this website is copyright the respective owners / authors. hdcn.com makes no claim of copyright on such material.For more information please visit:http://www.law.cornell.edu/uscode/17/107.shtml

TAGS:and Dialysis Hypertension 

<<< Thank you for your visit >>>

Hypertension, Dialysis, Kidney Disease, Nephrology, Nutrition information. For physicians, nurses, dietitians. Medical grand rounds, CME, CEU.

Hot Websites